基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 5,611.91
成立日期: 26/01/2004
 
分析
市值分佈:
96.94%
大市值
2.46%
中市值
0.58%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:37) 總持有投資項目: 413  
0%
 
100%
     10大 (52.04%)
代號 名稱 佔比% ▼ 持有日期
WGSGeneDx Holdings Corp0.0231/08/2026
ANIPANI Pharmaceuticals0.0231/07/2026
TNDMTandem Diabetes Care0.0231/08/2026
INSPInspire Medical Systems0.0231/08/2026
RXRXRecursion Pharmaceuticals0.0231/07/2026
VERAVera Therapeutics0.0231/08/2026
CNMDCONMED Corp0.0231/07/2026
INVAInnoviva0.0231/08/2026
SNDXSyndax Pharmaceuticals0.0231/08/2026
BFLYButterfly Network0.0231/08/2026
XERSXeris Biopharma Holdings0.0231/08/2026
ENOVEnovis Corp0.0231/08/2026
AZTAAzenta0.0231/08/2026
AMNAMN Healthcare Services Inc0.0231/08/2026
MBXMBX Biosciences Inc.0.0231/08/2026
XNCRXencor0.0231/08/2026
NVAXNovavax0.0231/08/2026
OMEROmeros Corp0.0231/08/2026
ESTAEstablishment Labs Holdings0.0231/08/2026
ALMSAlumis Inc.0.0231/08/2026
  1    2    3    4    5    6    7    8    9    10    11   12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.